Search Results for 'Drug Development'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Breaking News | Drug Development | Drug Discovery | Industry News
Lilly Completes $1B Acquisition of Prevail
Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.Kristin Brooks 01.22.21
-
Breaking News | Drug Development | Industry News | Information Technology | Regulatory Affairs
Top BioPharma Form Accumulus Synergy
Aims to develop a cloud-based Global Data Sharing Platform to facilitate data and information sharing between industry and health authorities worldwide.Kristin Brooks 01.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
AbbVie Licenses ProBioGen’s GlymaxX Technology
Will apply GlymaxX technology to boost the antibody-dependent cell-mediated cytotoxicity (ADCC).Kristin Brooks 01.22.21
-
Drug Development
Drug Development For Startups
There is no way to eliminate the risk of failure. However, there are ways to reduce these risks. Learn more in this whitepaper from Recipharm.
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Janssen, TenNor Enter NTM Research Pact
To leverage TenNor’s multitargeting drug conjugation platform to discover new therapies to treat nontuberculous mycobacteria diseases.Contract Pharma Staff 01.18.21
-
Clinical Trials | Drug Development | Information Technology
Virtual Clinical Trials: The Future of Dermatology Studies
COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
EVOQ Therapeutics and Amgen Partner
Collaborate on the discovery and development of novel drugs for autoimmune disorders.Contract Pharma Staff 01.13.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Adagene Achieves CAR-T Collaboration Milestone
Yields potential first-ever antibodies targeting human endogenous retrovirus associated with kidney cancer.Contract Pharma Staff 01.12.21
-
Analytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish
A New Era of Vaccine and Biologic Drug Development
As a result of COVID-19, unprecedented investments in vaccines, diagnostics, and treatments have had a tremendous impact on the Biotechnology industry.Online Exclusives Kristin Brooks, Managing Editor 01.12.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Cyclolab and EpiPharma Form Joint Venture
Will develop and commercialize Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.Contract Pharma Staff 01.11.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing
Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals
Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.Contract Pharma Staff 01.08.21
-
Clinical Trials | Drug Development
The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs
Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
BrickBio Inks ADC Co-Development Deal
To co-develop a therapeutic antibody drug conjugate (ADC) with a large pharmaceutical company.Contract Pharma Staff 01.06.21
-
Drug Development | Industry News | Regulatory Affairs
The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
Lantern Pharma Launches ADC Program
Will leverage RADR artificial intelligence platform to target solid tumors and blood cancers through agreement with Califia Pharma.Contract Pharma Staff 01.04.21
-
Clinical Trials | Drug Development
Impact of Decentralized Trials in Oncology Drug Development
Join us on 2/9 as clinical, regulatory and real-world evidence experts discuss the impact of decentralized trials on the evolution of drug dev in oncology.01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
Oncorus to Build GMP Viral Immunotherapy Mfg. Facility
88,000 sq.-ft. facility in Andover, MA will support multi-product pipeline of intratumorally and intravenously administered viral immunotherapies.Contract Pharma Staff 01.04.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, BMS Advance Targeted Protein Degradation Projects
The first two targets transition into drug discovery after completing a comprehensive target validation process.Contract Pharma Staff 12.17.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
INOVIO to Develop dMAb COVID Treatments under DARPA Grant
$37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.Contract Pharma Staff 12.15.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly to Acquire Prevail Therapeutics in $1B Deal
Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.Contract Pharma Staff 12.15.20
-
Breaking News | Clinical Trials | CRO News | Drug Development
Ergomed Acquires MedSource
Specialist oncology and rare disease CRO further expands Ergomed’s presence in the U.S. market.Contract Pharma Staff 12.15.20
-
Clinical Trials | Drug Development | Information Technology
Advancing Digital Endpoints in Clinical Trials
An end-to-end approach to managing wearable devices through clinical development.Online Exclusives Kristin Brooks, Contract Pharma 12.14.20
-
Clinical Trials | Drug Development | Information Technology
Advances in Intelligent Automation
The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA 12.14.20
-
Drug Development
Navigating Uncertainty: Considerations for Life Sciences 2021
With vaccines against COVID-19 on the horizon, our focus is shifting to 2021 and the major issues life sciences companies face and reasons for optimism.Arda Ural , EY Americas Health Sciences and Wellness Industry Leader, Ernst & Young LLP 12.11.20
-
Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
Ascentage Selects PharmaBlock as Preferred Provider
PharmaBlock will support Ascentage in accelerating its drug development pipeline with R&D, manufacturing capacity, and technological solutions.Contract Pharma Staff 12.11.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Orgenesis, Cure Therapeutics Form JV
Aims to advance point-of-care development and commercialization of cell and gene therapies.Contract Pharma Staff 12.10.20
-
Breaking News | Drug Development | Promotions & Moves
Catalent Appoints Minakuchi Facility GM
Nakaya “Nick” Matsumaru joins the company from SymBio Pharmaceuticals.Contract Pharma Staff 12.10.20
-
APIs | Drug Development | Drug Discovery
Why Do Integrated Services Matter?
From discovery to intermediates, APIs & drug products, a CDMO needs expertise across multiple elements of the pharma process to deliver an integrated experience
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly, UnitedHealth to Study Bamlanivimab in High-risk COVID-19
The study will identify and treat a large, diverse population of high-risk individuals for COVID-19 with bamlanivimab under real-world conditions.Contract Pharma Staff 12.04.20
-
Breaking News | Drug Development
ViGeneron and WuXi Advanced Therapies Enter Partnership
Will accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program.Contract Pharma Staff 12.02.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sterling Makes Strategic Investment in ADC Bio
Will work together to develop an integrated service offering combining ADC Bio’s expertise with Sterling’s high potency small molecule expertise.Contract Pharma Staff 12.02.20
-
Breaking News | Drug Development | Promotions & Moves
NeuBase Therapeutics Appoints Chief Scientific Officer
Dr. Curt Bradshaw brings decades of experience in successfully delivering genetic medicines to clinics.Contract Pharma Staff 12.02.20
-
Breaking News | Drug Development | Formulation Development | Industry News
Vectura, Kinaset Partner to Develop Asthma Treatment
Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.Contract Pharma Staff 11.30.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
Manufacturing at Wacker’s biotech site in Amsterdam is scheduled to start in the first half of 2021.Contract Pharma Staff 11.24.20
-
Drug Delivery | Drug Development
Inhaled Drug Delivery Technology Trends
The success of new inhaled medicines relies on the correct combination of formulation and device technology.Online Exclusives Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20
-
Breaking News | Drug Development | Trials & Filings
Regeneron's COVID-19 Antibody Cocktail Gets EUA
Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.Contract Pharma Staff 11.23.20
-
Breaking News | Collaborations & Alliances | Drug Development
Amgen Ends Cardio Alliance with Cytokinetics
Will transition the development and commercialization rights for omecamtiv mecarbil to Cytokinetics and Servier.Contract Pharma Staff 11.23.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track
Initiation of ASPEN-COVID-19 Phase 2b clinical trial anticipated in December with trial data anticipated 2Q21.Contract Pharma Staff 11.23.20
-
Collaborations & Alliances | Drug Development
Cue Biopharma, Merck Extend Biologics Research Alliance
To develop clinical candidate for the treatment of type 1 diabetes and an additional undisclosed autoimmune disease.Contract Pharma Staff 11.19.20
-
Biologics, Proteins, Vaccines | Biosimilars | Drug Development
Biopharma Contract Manufacturing: Robust Growth Ahead
The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.William Downey, HighTech Business Decisions 11.17.20
-
Bioassay Development | Biologics, Proteins, Vaccines | Drug Development | Facilities
Opportunities in Synthetic Biology
Les Tillack, CEO of Luina Bio, discusses how ‘synbio’ is driving growth in the biopharma industry.Contract Pharma Staff
-
Collaborations & Alliances | Drug Development
XOMA Earns $2M Takeda Milestone
Mezagitamab advances into Phase 2 development in generalized myasthenia gravis.Contract Pharma Staff 11.17.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Swissmedic Begins Rolling Review of Moderna’s mRNA COVID-19 Vax
Moderna completed enrollment of its Phase 3 COVE study of mRNA-1273 on October 22.Contract Pharma Staff 11.13.20
-
Breaking News | Drug Delivery | Drug Development | Industry News
Novo Nordisk to Acquire Emisphere Technologies
Gains the Eligen SNAC oral delivery technology.Contract Pharma Staff 11.13.20
-
Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
CDMOs: Keeping up with Science & Technology
Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.Online Exclusives Kristin Brooks, Contract Pharma 11.12.20
-
Drug Delivery | Drug Development | Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids
Exploring the World of Medicated Chewing Gum
Chewing gum as a dosage format for pharmaceutical applications in the OTC market stands out as a fast growing, innovative dosage format.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Gilead Bolsters Biologics Capabilities
Licenses ProteoNic’s 2G UNic Technology Platform for production of biologics.Contract Pharma Staff 11.10.20
-
Drug Delivery | Drug Development | Trials & Filings
Impel NeuroPharma Submits NDA for INP104 in Acute Migraine
Leverages the company’s Precision Olfactory Delivery technology11.09.20
-
Breaking News | Drug Development | Promotions & Moves
Inozyme Pharma Appoints SVP, Regulatory Affairs
Dr. Kevin B. Johnson brings over 25 years of experience to the role.Contract Pharma Staff 11.09.20
-
Breaking News | Collaborations & Alliances | Drug Development
PhoreMost, Oxford Biomedica Enter CAR-T Collaboration
Aims to develop next-gen CAR-T cell therapies leveraging SITESEEKER and LentiVector platforms.Contract Pharma Staff 11.09.20
